Position
Sovran Advisors, LLC in Pfizer Inc
Back to the book · All holders of PFE
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $15.7K$25.89 → $26.70
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 19.4K | $501.2K | — | — | — | 0.0% |
| Q1 2026 | 24.3K | $650K | $26.70 | $15.7K | $133.2K | 0.1% |